NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 15, 2025, the company granted restricted stock units (RSUs) with respect to 1,875 shares of the company’s common stock to two newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement t
Related Questions
How does the compensation expense from these grants affect EPS guidance for the upcoming quarters?
How might the market react to the announcement of new hires receiving sizable equity grants?
How many total shares will be outstanding after these RSU grants and what is the resulting dilution percentage?
What is the vesting schedule and performance conditions (if any) attached to the RSUs?
Are these RSU grants part of a broader hiring or expansion strategy that could impact revenue growth?
How does the size of this inducement grant compare to recent hires or similar grants at peer biotech companies?
What is the estimated impact of these RSU grants on the company's cash flow and operating expenses?
Will the board’s delegation to the compensation committee affect future governance or approval processes for similar grants?
What is the average cost per share for the RSUs at the grant date, and how does that compare to the current market price?
Is there any risk of increased insider selling or lock‑up periods associated with these RSU grants?